Approximately one year after the company landed FDA approval for its Ventricular Assist System, the company is boasting significant surge in revenue. In early morning trading on November 7, the ...

MOMENTUM 3 Study meets primary endpoint for short-term indication Results presented during late-breaking clinical trial session at the AHA Scientific Sessions MOMENTUM 3 Study data published in the ...

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.

Pediatric ventricular assist devices (VADs) and mechanical circulatory support systems have emerged as critical tools in the management of children with end‐stage heart failure, including those with ...

SILVER SPRING, Maryland — As expected, the FDA has approved the HeartWare Ventricular Assist System (HeartWare, Framingham, MA) as bridge therapy for patients awaiting heart transplantation [1]. In ...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, ...

The DuraHeart Left-Ventricular Assist System, or “LVAS,” from Terumo Heart was featured at a recent health technology event. DuraHeart LVAS is a next-generation medical device designed to help sustain ...

Baptist Health is breaking new ground as the first and only health system in Arkansas to participate in the INNOVATE Trial, ...

Baptist Health has become the first health system in the state of Arkansas to participate in a clinical trial to evaluate a new treatment for advanced heart failure.

New York, April 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Ventricular Assist Device Market - Premium Insight, Competitive News Feed Analysis, Company ...